Hattie Hayes is the editor of Ophthalmology Times Europe.
International Glaucoma Surgical Registry and Elios Vision announce partnership
The open-access tool is the official registry partner of the European Glaucoma Society.
Elios Vision completes enrollment for pivotal US clinical trial
The company seeks to replicate European success of the ELIOS procedure in the US market.
Santen releases long-term data on PRESERFLO® MicroShunt and Endothelial Cell Density loss
The pharmaceutical company will present study results at the World Glaucoma Congress.
Oculis announces R&D Retina Day, showcasing global experts in clinical programs
The live streamed event will cover topics including DME, CME, AON and more.
Optogenetics researchers win International Prize for Translational Neuroscience
The two winners were awarded a €60,000 prize for their work to treat degenerative retinal disease.
Australian study tallies cost of genetic eye disease at $5.2 million per patient
Researchers totaled the societal and healthcare costs of inherited retinal diseases.
Rodenstock debuts MyCon corrective spectacle lenses for childhood myopia
The lenses are designed to correct and prevent myopia in children ages 6 to 14.
Video Recap: European Society of Ophthalmology 2023
Did you miss the 2023 European Society of Ophthalmology congress? Don't worry – you can catch up with our video coverage.
SOE 2023: What new surgeries will hit the glaucoma market?
Ophthalmology Times Europe© is proud to cover the European Society of Ophthalmology 2023. We spoke to SOE presenter Panayiota Founti, PhD, FEBO, Consultant Ophthalmic Surgeon & Training Director, Glaucoma Service Moorfields Eye Hospital, London, UK.
Syncona launches ophthalmic gene therapy venture Beacon Therapeutics
The new company debuted with £96 million in funding to target retinal diseases.
ESCRS visual optics e-learning portal re-accredited for CME
The EACCME accreditation is renewed through 2025.
New NHS guidance established to improve eye care accessibility in England
Clinical ophthalmology efforts will target the 'busiest' outpatient speciality.
Federal investment and regulatory benefits draw biotech firms to Switzerland
The country is home to 20% of biotechs headquartered in Europe.
UK patients with vision loss confused by ‘disjointed’ benefits registration system
Accessibility obstacles could prevent those with sight loss from receiving support and care.
Late spring heatwave poses vision risk to populations across Europe
What ophthalmologists want patients to know ahead of UK bank holiday.
WHO validates Benin and Mali for eliminating trachoma as public health problem
The countries join 15 other nations that have eliminated the disease.
For medical students, supervision is vital to a positive learning experience
Physician supervision stood out as the major determining factor behind ‘excellent’ learning outcomes in a clinical environment.
Predicting childhood myopia and applying prevention measures
Identifying pre-myopia creates an opportunity to deploy accessible prevention strategies, which could reduce prevalence of myopia in children.
2 Clarke Drive Cranbury, NJ 08512